HiLabs Study Featured in MedPAC June 2024 Report to Congress Highlights Alarming Inconsistencies in Provider Directories

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BETHESDA, Md., June 27, 2024 /PRNewswire/ — HiLabs, a leader in AI-powered solutions for healthcare data management, is proud to announce that a study utilizing HiLabs technology and conducted by its Chief Medical Officer, Dr. Neel Butala, has been prominently featured in the Medicare Payment Advisory Commission’s June report to Congress in its discussion of Medicare Advantage Provider Networks. The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises the U.S. Congress on the Medicare program.

The HiLabs study, initially published in the Journal of the American Medical Association (JAMA), highlights significant discrepancies in provider directories, raising concerns about the impact on patients’ access to timely care. The study examined data from 449,282 U.S. physicians and found that 81% of provider entries had inconsistencies across five major health plans. This widespread issue underscores the urgent need for improved provider data management practices.

“We are honored to have our study recognized in the MedPAC report to Congress,” said Dr. Neel Butala, the lead author of the study. “These findings illuminate a critical problem that affects patient care. Provider directory accuracy is essential for ensuring patients have access to the right care, at the right time.”

The study’s findings have significant implications for both healthcare providers and patients. Inaccurate provider directories can lead to delayed care, surprise billing, and the creation of ghost networks. These issues have recently drawn the attention of regulators and lawmakers. An increasing amount of legislation, such as the No Surprises Act, focuses on protecting patients from issues that stem from errors in provider data.

“This recognition by MedPAC is a testament to the critical importance of accurate provider data,” said Amit Garg, CEO of HiLabs. “Highlighting the study’s impact in such a prominent report is an important example of how AI solutions can effectively address real-world challenges. By leveraging advanced AI technology, we were able to identify and analyze discrepancies in provider directories, showcasing the practical applications of AI in healthcare to improve patient outcomes.”

About HiLabs
HiLabs is a leading provider of AI-powered solutions that clean dirty data, unlocking its hidden potential for healthcare transformation. HiLabs is committed to transforming the healthcare industry through innovation, collaboration, and a relentless focus on improving patient outcomes. For more information, please visit hilabs.com or contact info@hilabs.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hilabs-study-featured-in-medpac-june-2024-report-to-congress-highlights-alarming-inconsistencies-in-provider-directories-302184662.html

SOURCE HiLabs

Staff

Recent Posts

The Michael J. Fox Foundation for Parkinson’s Research Applauds Texas Voters on Passage of Proposition 14 Securing $3 Billion for Brain Disease Research

The ballot measure was supported by national and local neurodegenerative disease organizations, including The Michael…

2 hours ago

Medtronic to announce financial results for its second quarter of fiscal year 2026

GALWAY, Ireland, Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare…

2 hours ago

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

SAN DIEGO, Nov. 5, 2025 /PRNewswire/ -- The Chinese Ministry of Commerce (MOFCOM) today announced it…

2 hours ago

Columbus McKinnon to Present at the 2025 Baird Global Industrial Conference

CHARLOTTE, N.C., Nov. 5, 2025 /PRNewswire/ -- Columbus McKinnon Corporation (Nasdaq: CMCO) ("Columbus McKinnon" or the…

2 hours ago

StemCyte Launches First Insurance-Linked Public Cord Blood Access in Taiwan, Setting a New Standard in Cell Therapy Protection

BALDWIN PARK, Calif., Nov. 5, 2025 /PRNewswire/ -- StemCyte International (TPEX: 4178), a global leader…

2 hours ago

Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Revenue growth of 113% driven by strong performance in molecular profiling services Raises 2025 revenue…

2 hours ago